Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Brain Research(2016)
Abstract
•MicroRNA-21 participates in the neuroprotective effect of geniposide in Parkinson's disease.•MicroRNA-21 enhances α-synuclein expression via targeting LAMP2A.•Geniposide promotes LAMP2A and inhibits in α-synuclein Parkinson's disease.•We found a potential mechanism underlying the neuroprotective effect of geniposide.
MoreTranslated text
Key words
Geniposide,Parkinson disease,MiR-21,LAMP2A,α-synuclein
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined